IHH Healthcare Deepens Commitment to Reduce Cancer Burden in Malaysia - IHH Healthcare
  • Join our community
  • IHH@LinkedIn
  • IHH@Youtube
  • IHH@Facebook
IHH Healthcare Deepens Commitment to Reduce Cancer Burden in Malaysia
08 Jul 2025

Learn how our third memorandum of understanding with Ministry of Health Malaysia is expanding access to life-saving, advanced cancer care at 8 of our hospitals.

 

 

IHH Healthcare Malaysia has inked its third Memorandum of Understanding (MOU) with the Ministry of Health Malaysia, reaffirming our commitment to making advanced cancer treatment accessible to more Malaysians.

The collaboration will fully sponsor radiotherapy and radiosurgery for an additional 500 patients referred from government hospitals. Since its launch in 2022, this public-private initiative has enabled 1,000 cancer patients to receive high-quality treatment at no cost through our Malaysia hospital network.

"This collaboration is a concrete step toward closing the access gap for underserved and lower-income groups. It also reflects Malaysia's broader commitment to Universal Health Coverage, where cancer care is not treated as a privilege but as a right. We should never allow a patient's health outcome to be dictated by where they live or how much they earn,” said Health Minister, YB Datuk Seri Dr Haji Dzulkefly Ahmad during the signing ceremony held at the Malaysia Ministry of Health Multipurpose Hall on 7 July 2025.

This latest agreement will also include Island Hospital Penang, bringing the total number of participating IHH Healthcare Malaysia hospitals to eight. The other seven participating hospitals are Gleneagles Hospital Johor, Gleneagles Hospital Kuala Lumpur, Gleneagles Hospital Penang, Pantai Hospital Ayer Keroh, Pantai Hospital Kuala Lumpur, Pantai Hospital Penang and Prince Court Medical Centre.

"Public-private partnerships play an important role in bridging healthcare gaps, especially for life-threatening illnesses like cancer. By renewing our partnership, we are taking another step forward in our shared mission of making timely, high-quality care more accessible to those who need it most," said IHH Healthcare Chairman Tan Sri Dr Nik Norzrul Thani bin Nik Hassan Thani. 

Under the MOU, patients will be able to receive care at our facilities equipped with advanced technologies such as Gamma Knife and Linear Accelerator (LINAC). These allow for precision tumour targeting while preserving healthy tissue. The initiative also supports the goals outlined in Malaysia’s National Cancer Control Blueprint, particularly the need for earlier intervention and broader access to cancer services.

“Cancer care is not just about cutting-edge equipment. It is also about compassion and commitment. We know the financial burden can be overwhelming, especially in today’s environment. By renewing this MOU, we are reaffirming our role in supporting the public healthcare system and easing that burden where we can," said IHH Healthcare Group CEO Dr Prem Kumar Nair.

“This partnership began with a clear purpose: to close the gap in access to timely, quality cancer care. Treating 1,000 patients so far shows the real impact of that commitment. As we enter this next phase, we remain focused on working with the MOH to ensure more patients receive the care they need, when they need it,” said IHH Healthcare Malaysia CEO Jean-François Naa.

The renewed partnership strengthens our commitment to building a more sustainable healthcare ecosystem. By combining advanced clinical capabilities with our aspiration to Care. For Good., we are catalysing positive change and making quality healthcare more accessible to the communities we serve.

Related Stories

Acibadem Robie The Robot Thumbnails June 2026

ROBIE the Robot Transforms Acibadem's Smart Hospital Logistics

Acibadem pioneered smart hospital logistics in Türkiye by introducing ROBIE, an autonomous mobile robot, designed to elevate operational excellence.

08 Jul 2025
Read More
Parkway Shanghai Integrated Chinese and Western Medicine Health Management Services Thumbnail J

Parkway MediCentre Xintiandi Launches Integrated Chinese and Western Medicine Health Management Services

Themed "Echoes of the World, Pulse of China", Parkway MediCentre Xintiandi showcased the role of Traditional Chinese Medicine (TCM) through an integrated healthcare approach.

08 Jul 2025
Read More
Fortis Memorial Research Institute CoE for Myeloma & Lymphoma June 2026 Thumbnail

Fortis Memorial Research Institute (FMRI) Launches India's First Centre of Excellence for Myeloma and Lymphoma

Officiated on 11 June, the FMRI Centre of Excellence, brings a highly specialised, patient‑centred and research‑driven approach to managing blood cancers.

08 Jul 2025
Read More

Gleneagles Hospital Hong Kong Delivers Seamless Musculoskeletal Care

Gleneagles Hospital Hong Kong is strengthening musculoskeletal (MSK) care through closer collaboration, bringing together insurers and healthcare providers to support a more connected and patient-centred treatment journey.

08 Jul 2025
Read More

IHH Healthcare Singapore Recognised for Building Meaningful Employee Experiences

IHH Healthcare Singapore has been recognised with six wins at the 2026 Employee Experience Awards, a regional platform celebrating organisations that create meaningful, people-centric workplaces.
08 Jul 2025
Read More

Gleneagles Hospital Singapore showcased Enhanced Recovery After Surgery (ERAS®) programme at 12th ERAS® World Congress

Gleneagles Hospital Singapore is advancing surgical recovery through its adoption of the Enhanced Recovery After Surgery (ERAS®) programme, recognised for its early implementation in Singapore’s private healthcare sector.

08 Jul 2025
Read More
HOSPITALS
PRIMARY CARE
ANCILLARY SERVICES
  • Acibadem Labmed Logo
  • Agilus Diagnostics Logo
  • Parkway Laboratories
  • Parkway Radiology Logo
  • Parkway Rehab Logo
  • Premier Integrated Labs Logo
  • Premier Integrated Rehab Logo